RPS6KA3 and glioblastoma: Similarly, RSK2 gene knock-down with shRNA and chemical inhibition significantly blocked GBM SK748 invasion in transwell assays with epidermal growth factor (EGF) and fibroblast growth factor (FGF) as chemoattractants (Figure 5D).